ESC Premium Access

Cardiovascular risk management in the era of SGLT2is

Topic: Cardiovascular Disease in Special Populations
Sponsored by the Mundipharma network of independent associated companies

Congress Presentation

About the speaker

Professor Martin Cowie

AstraZeneca, Cambridge (United Kingdom of Great Britain & Northern Ireland)
112 presentations
5 followers

3 more presentations in this session

Welcome and objectives.

Speaker: Professor F. Cosentino (Stockholm, SE)

Thumbnail

Heart failure with and without chronic kidney disease in type 2 diabetes

Speaker: Professor O. Schnell (Munich, DE)

Thumbnail

Interactive panel discussion

Speaker: Professor F. Cosentino (Stockholm, SE) Professor M. Cowie (Cambridge, GB) Professor O. Schnell (Munich, DE)

Thumbnail

Access the full session

Rewriting the textbooks: SGLT2 inhibitors and cardiovascular disease in type 2 diabetes

Speakers: Professor M. Cowie, Professor F. Cosentino, Professor O. Schnell, Professor F. Cosentino, Professor M. Cowie...
Thumbnail

About the event

Image

ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb